/PRNewswire/ Regenesis Biomedical, Inc., a medical device company focused on safe, non-drug, pain management, announced today commercialization of the new.
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Regenesis Biomedical Names Tom Eisiminger, Jr., Chief Executive Officer
January 11, 2021 GMT
Safe, Non-Drug, Pain Management
SCOTTSDALE, Ariz., Jan. 11, 2021 /PRNewswire/ Regenesis Biomedical, Inc., a medical device company focused on safe, non-drug, pain management, announced today that the Board of Directors has unanimously elected Mr. Tom Eisiminger, Jr., as the next President and Chief Executive Officer (CEO), and member of the Board of Directors. Mr. Eisiminger succeeds Mr. Scott Brooks who recently retired.
Scott Brooks’ career spanned senior management positions in BSN medical, KCI, Hill-Rom Company and Kimberly-Clark Healthcare, across sales and marketing, business development, national accounts, and operations. Scott served as Chief Operating Officer (COO) and CEO of Regenesis, where he helped shape corporate strategy for market expansion. Regenesis thanks Scott for his guida